CD8A and neoplasm: The frequency of intratumoral NKG2A/CD94+ CD8+ T cells was higher in in HPV16+ OPSCC patients with a demonstrable ongoing HPV16-specific T cell response when compared to HPV16+ OPSCC lacking such an anti-tumor response or to HPV-negative OPSCC patients (6, 97).